LEFMARDY-20 TABLETS
LEFMARDY-20 TABLETS
Product Details :
| Feature | Details |
|---|---|
| Product Name | LEFMARDY-20 Tablets |
| Form | Oral Tablets |
| Key Ingredient | Leflunomide 20 mg |
| Therapeutic Class | DMARD (Disease-Modifying Antirheumatic Drug) |
| Core Benefits | Reduces joint inflammation, prevents progression of arthritis |
| Mechanism of Action | Inhibits dihydroorotate dehydrogenase → suppresses immune cell proliferation |
Brand Name: Lefmardy 20 Tablets Description: This drug was originally developed to treat rheumatoid arthritis (RA). However, it is now commonly prescribed for the treatment of psoriatic arthritis (PsA). Leflunomide’s mechanism of action is not completely understood; however, it is believed that it may inhibit certain enzymes involved in the inflammatory cascade.